Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) reports the results of the company's Ninth Annual General Meeting (AGM) held on May 20, 2009. The document details shareholder voting outcomes on 18 resolutions, including financial statement adoption, board elections, and corporate governance matters.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting statistics.
Material Changes and Voting Results
All 18 resolutions presented at the AGM were passed by shareholders. Key voting statistics include:
- Financial Statements: Adopted with 98.71% of votes cast in favor.
- Board Elections: All director elections and re-elections (including James Murdoch, Larry Culp, Sir Crispin Davis, Dr. Moncef Slaoui, and Tom de Swaan) received support exceeding 98%.
- Remuneration Report: Approved with 97.40% support.
- Share Capital: Issued share capital (excluding Treasury Shares) decreased to 5,188,385,638 in 2009 from 5,352,175,102 in 2008.
- Shareholder Participation: Total votes cast and withheld represented 73.50% of issued share capital, a slight decrease from 73.78% in 2008.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural report confirming the successful passage of standard AGM resolutions.
Investor Verification Checklist
- Verify the specific financial performance figures for the period ending May 2009 in the company's Form 20-F or annual report, as they are not included in this 6-K.
- Confirm the details of the newly adopted 2009 Performance Share Plan, Share Option Plan, and Deferred Annual Bonus Plan referenced in the voting results.
- Review the reduction in issued share capital between 2008 and 2009 to understand the impact of share buybacks or treasury share adjustments.
- Check the company website (www.gsk.com) for the full text of the resolutions and any supplementary materials referenced in the filing.